General Information of This Target
Target ID
PATR0CMGNI
Target Name
Protein cereblon (CRBN)
Gene Name
CRBN
Gene ID
51185
Synonym
AD-006
Sequence
MAGEGDQQDAAHNMGNHLPLLPAESEEEDEMEVEDQDSKEAKKPNIINFDTSLPTSHTYL
GADMEEFHGRTLHDDDSCQVIPVLPQVMMILIPGQTLPLQLFHPQEVSMVRNLIQKDRTF
AVLAYSNVQEREAQFGTTAEIYAYREEQDFGIEIVKVKAIGRQRFKVLELRTQSDGIQQA
KVQILPECVLPSTMSAVQLESLNKCQIFPSKPVSREDQCSYKWWQKYQKRKFHCANLTSW
PRWLYSLYDAETLMDRIKKQLREWDENLKDDSLPSNPIDFSYRVAACLPIDDVLRIQLLK
IGSAIQRLRCELDIMNKCTSLCCKQCQETEITTKNEIFSLSLCGPMAAYVNPHGYVHETL
TVYKACNLNLIGRPSTEHSWFPGYAWTVAQCKICASHIGWKFTATKKDMSPQKFWGLTRS
ALLPTIPDTEDEISPDKVILCL

    Click to Show/Hide
Family
the CRBN family
Function
Substrate recognition component of a DCX (DDB1-CUL4-X-box) E3 protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteinssuch as MEIS2 or ILF2. Normal degradation of key regulatory proteins is required for normal limb outgrowth and expression of the fibroblast growth factor FGF8. Maintains presynaptic glutamate release and consequently cognitive functionssuch as memory and learningby negatively regulating large-conductance calcium-activated potassium (BK) channels in excitatory neurons. Likely to function by regulating the assembly and neuronal surface expression of BK channels via its interaction with KCNT1. May also be involved in regulating anxiety-like behaviors via a BK channel-independent mechanism. Plays a negative role in TLR4 signaling by interacting with TRAF6 and ECSITleading to inhibition of ECSIT ubiquitinationan important step of the signaling.

    Click to Show/Hide
Uniprot Entry
CRBN_HUMAN
HGNC ID
HGNC:30185
KEGG ID
hsa:51185
Full List of The ADC Related to This Target
Investigative
Click To Hide/Show 90 ADC Related to This Stage
ADC Info ADC Name Antibody Antigen Payload Linker Ref
Rituximab-Compound (la) DAR 8
Rituximab
MS4A1
NeoDegrader P1
Rituximab-Compound (la) linker
[1]
Pertuzumab-Compound(la)
Pertuzumab
ERBB2
NeoDegrader P1
Pertuzumab-Compound(la) linker
[1]
Trastuzumab-Compound (la) DAR 1.6
Trastuzumab
ERBB2
NeoDegrader P1
Trastuzumab-Compound (la) DAR 1.6 linker
[1]
Trastuzumab-Compound (la) DAR 8
Trastuzumab
ERBB2
NeoDegrader P1
Trastuzumab-Compound (la) DAR 8 linker
[1]
Pertuzumab-Compound (la) DAR 8
Pertuzumab
ERBB2
NeoDegrader P1
Pertuzumab-Compound (la) DAR 8 linker
[1]
OR000213-Compound (Ia)
OR000213
CD33
NeoDegrader P1
OR000213-Compound (Ia) linker
[1]
huMy9-6IgG1-Compound (la) DAR 8
huMy9-6 IgG1
CD33
NeoDegrader P1
huMy9-6IgG1-Compound (la) DAR 8 linker
[1]
Lintuzumab IgG1-Compound (la) DAR 8
Lintuzumab
CD33
NeoDegrader P1
Lintuzumab IgG1-Compound (la) DAR 8 linker
[1]
OR000213-Compound(la) DAR 8
OR000213
CD33
NeoDegrader P1
OR000213-Compound(la) DAR 8 linker
[1]
huMy9-6 IgG1-Compound (la) DAR 1.9
huMy9-6 IgG1
CD33
NeoDegrader P1
huMy9-6 IgG1-Compound (la) DAR 1.9 linker
[1]
huMy9-6IgG1-Compound (la) DAR3.9
huMy9-6 IgG1
CD33
NeoDegrader P1
huMy9-6IgG1-Compound (la) DAR3.9 linker
[1]
huMy9-6IgG1-Compound(la) DAR 5.5
huMy9-6 IgG1
CD33
NeoDegrader P1
huMy9-6IgG1-Compound(la) DAR 5.5 linker
[1]
OR000213-Compound (la) DAR 1.2
OR000213
CD33
NeoDegrader P1
OR000213-Compound (la) DAR 1.2 linker
[1]
OR000213-Compound(la) DAR 1.8
OR000213
CD33
NeoDegrader P1
OR000213-Compound(la) DAR 1.8 linker
[1]
OR000213-Compound(la) DAR 2.3
OR000213
CD33
NeoDegrader P1
OR000213-Compound(la) DAR 2.3 linker
[1]
Trastuzumab-Compound (Ib) DAR1.5
Trastuzumab
ERBB2
NeoDegrader P3
Trastuzumab-Compound (Ib) DAR1.5 linker
[1]
Trastuzumab-Compound (lc)
Trastuzumab
ERBB2
NeoDegrader P4
Trastuzumab-Compound (lc) linker
[1]
Rituximab-Compound (lc)
Rituximab
MS4A1
NeoDegrader P4
Rituximab-Compound (lc) linker
[1]
Pertuzumab-Compound(lc)
Pertuzumab
ERBB2
NeoDegrader P4
Pertuzumab-Compound(lc) linker
[1]
Trastuzumab-Compound (lc) DAR 8
Trastuzumab
ERBB2
NeoDegrader P4
Trastuzumab-Compound (lc) DAR 8 linker
[1]
Pertuzumab-Compound (lc) DAR 8
Pertuzumab
ERBB2
NeoDegrader P4
Pertuzumab-Compound (lc) DAR 8 linker
[1]
Trastuzumab-Compound (ld) DAR 1.6
Trastuzumab
ERBB2
NeoDegrader P1
Trastuzumab-Compound (ld) DAR 1.6 linker
[1]
huMy9-6IgG1-Compound (ld) DAR 8
huMy9-6 IgG1
CD33
NeoDegrader P1
huMy9-6IgG1-Compound (ld) DAR 8 linker
[1]
Lintuzumab IgG1-Compound (ld) DAR 8
Lintuzumab
CD33
NeoDegrader P1
Lintuzumab IgG1-Compound (ld) DAR 8 linker
[1]
Trastuzumab-Compound (le)
Trastuzumab
ERBB2
NeoDegrader P1
Trastuzumab-Compound (le) linker
[1]
Rituximab-Compound (le)
Rituximab
MS4A1
NeoDegrader P1
Rituximab-Compound (le) linker
[1]
Pertuzumab-Compound (le)
Pertuzumab
ERBB2
NeoDegrader P1
Pertuzumab-Compound (le) linker
[1]
Trastuzumab-Compound (lf)
Trastuzumab
ERBB2
NeoDegrader P6
Trastuzumab-Compound (lf) linker
[1]
Rituximab-Compound (lf)
Rituximab
MS4A1
NeoDegrader P6
Rituximab-Compound (lf) linker
[1]
Pertuzumab-Compound (lf)
Pertuzumab
ERBB2
NeoDegrader P6
Pertuzumab-Compound (lf) linker
[1]
Trastuzumab-Compound (lg)
Trastuzumab
ERBB2
NeoDegrader P2
Trastuzumab-Compound (lg) linker
[1]
Rituximab-Compound (lg)
Rituximab
MS4A1
NeoDegrader P2
Rituximab-Compound (lg) linker
[1]
Pertuzumab-Compound (lg)
Pertuzumab
ERBB2
NeoDegrader P2
Pertuzumab-Compound (lg) linker
[1]
Trastuzumab-Compound (lh)
Trastuzumab
ERBB2
NeoDegrader P13
Trastuzumab-Compound (lh) linker
[1]
Rituximab-Compound (lh)
Rituximab
MS4A1
NeoDegrader P13
Rituximab-Compound (lh) linker
[1]
Pertuzumab-Compound (lh)
Pertuzumab
ERBB2
NeoDegrader P13
Pertuzumab-Compound (lh) linker
[1]
Trastuzumab-Compound (li)
Trastuzumab
ERBB2
NeoDegrader P1
Trastuzumab-Compound (li) linker
[1]
Rituximab-Compound (li)
Rituximab
MS4A1
NeoDegrader P1
Rituximab-Compound (li) linker
[1]
Pertuzumab-Compound (li)
Pertuzumab
ERBB2
NeoDegrader P1
Pertuzumab-Compound (li) linker
[1]
Trastuzumab-Compound (lk)
Trastuzumab
ERBB2
NeoDegrader P14
Trastuzumab-Compound (lk) linker
[1]
Rituximab-Compound (lk)
Rituximab
MS4A1
NeoDegrader P14
Rituximab-Compound (lk) linker
[1]
Pertuzumab-Compound (lk)
Pertuzumab
ERBB2
NeoDegrader P14
Pertuzumab-Compound (lk) linker
[1]
Trastuzumab-Compound (ll)
Trastuzumab
ERBB2
NeoDegrader P14
Trastuzumab-Compound (ll) linker
[1]
Rituximab-Compound (ll)
Rituximab
MS4A1
NeoDegrader P14
Rituximab-Compound (ll) linker
[1]
Pertuzumab-Compound (ll)
Pertuzumab
ERBB2
NeoDegrader P14
Pertuzumab-Compound (ll) linker
[1]
Trastuzumab-Compound (lm)
Trastuzumab
ERBB2
NeoDegrader P14
Trastuzumab-Compound (lm) linker
[1]
Rituximab-Compound (lm)
Rituximab
MS4A1
NeoDegrader P14
Rituximab-Compound (lm) linker
[1]
Pertuzumab-Compound (lm)
Pertuzumab
ERBB2
NeoDegrader P14
Pertuzumab-Compound (lm) linker
[1]
Rituximab-Compound (la) DAR 4
Rituximab
MS4A1
NeoDegrader P1
Rituximab-Compound (la) linker
[1]
HuAT12/5-Compound (Ia)
HuAT12/5
CD38
NeoDegrader P1
HuAT12/5-Compound (Ia) linker
[1]
Isatuximab-Compound (Ia)
Isatuximab
CD38
NeoDegrader P1
Isatuximab-Compound (Ia) linker
[1]
Daratumumab-Compound (Ia)
Daratumumab
CD38
NeoDegrader P1
Daratumumab-Compound (Ia) linker
[1]
Indatuximab-Compound (Ia)
Indatuximab
CD38
NeoDegrader P1
Indatuximab-Compound (Ia) linker
[1]
Belantamab-Compound (Ia)
Belantamab
TNFRSF17
NeoDegrader P1
Belantamab-Compound (Ia) linker
[1]
Sacituzumab-Compound (Ia)
Sacituzumab
TACSTD2
NeoDegrader P1
Sacituzumab-Compound (Ia) linker
[1]
U3-1784-Compound (Ia)
U3-1784
FGFR4
NeoDegrader P1
U3-1784-Compound (Ia) linker
[1]
Cetuximab-Comound (Ia)
Cetuximab
EGFR
NeoDegrader P1
Cetuximab-Comound (Ia) linker
[1]
Olaratumab-Compound (Ia)
Olaratumab
PDGFRA
NeoDegrader P1
Olaratumab-Compound (Ia) linker
[1]
Ontuxizumab-Compound (Ia)
Ontuxizumab
CD248
NeoDegrader P1
Ontuxizumab-Compound (Ia) linker
[1]
Anti-CD33AB-Compound (Ia)
Anti-CD33AB
CD33
NeoDegrader P1
Anti-CD33AB-Compound (Ia) linker
[2]
Anti-CD33AB-Compound (Ib)
Anti-CD33AB
CD33
NeoDegrader P1
Anti-CD33AB-Compound (Ib) linker
[2]
Anti-CD33AB-Compound (Ic)
Anti-CD33AB
CD33
NeoDegrader P1
Anti-CD33AB-Compound (Ic) linker
[2]
Anti-CD33AB-Compound (Ie)
Anti-CD33AB
CD33
NeoDegrader P1
Anti-CD33AB-Compound (Ie) linker
[2]
Anti-CD33AB-Compound (Ih)
Anti-CD33AB
CD33
NeoDegrader P1
Anti-CD33AB-Compound (Ih) linker
[2]
Gemtuzumab-Compound (Ia)
Gemtuzumab
CD33
NeoDegrader P1
Gemtuzumab-Compound (Ia) linker
[2]
Gemtuzumab-Compound (Ib)
Gemtuzumab
CD33
NeoDegrader P1
Gemtuzumab-Compound (Ib) linker
[2]
Gemtuzumab-Compound (Ic)
Gemtuzumab
CD33
NeoDegrader P1
Gemtuzumab-Compound (Ic) linker
[2]
Gemtuzumab-Compound (Ie)
Gemtuzumab
CD33
NeoDegrader P1
Gemtuzumab-Compound (Ie) linker
[2]
Gemtuzumab-Compound (Ih)
Gemtuzumab
CD33
NeoDegrader P1
Gemtuzumab-Compound (Ih) linker
[2]
huMy9-6-IgG4-S228P-Compound (Ia)
huMy9-6-IgG4-S228P
CD33
NeoDegrader P1
huMy9-6-IgG4-S228P-Compound (Ia) linker
[2]
huMy9-6-IgG4-S228P-Compound (Ib)
huMy9-6-IgG4-S228P
CD33
NeoDegrader P1
huMy9-6-IgG4-S228P-Compound (Ib) linker
[2]
huMy9-6-IgG4-S228P-Compound (Ic)
huMy9-6-IgG4-S228P
CD33
NeoDegrader P1
huMy9-6-IgG4-S228P-Compound (Ic) linker
[2]
huMy9-6-IgG4-S228P-Compound (Ie)
huMy9-6-IgG4-S228P
CD33
NeoDegrader P1
huMy9-6-IgG4-S228P-Compound (Ie) linker
[2]
huMy9-6-IgG4-S228P-Compound (Ih)
huMy9-6-IgG4-S228P
CD33
NeoDegrader P1
huMy9-6-IgG4-S228P-Compound (Ih) linker
[2]
Anti-CD33 AB1 Compound (Ia)
Anti-CD33 AB1
CD33
NeoDegrader P1
Anti-CD33 AB1 Compound (Ia) linker
[3]
Anti-CD33 AB1 Compound (Ib)
Anti-CD33 AB1
CD33
NeoDegrader P1
Anti-CD33 AB1 Compound (Ib) linker
[3]
Anti-CD33 AB1 Compound (Ic)
Anti-CD33 AB1
CD33
NeoDegrader P1
Anti-CD33 AB1 Compound (Ic) linker
[3]
Anti-CD33 AB1 Compound (Id)
Anti-CD33 AB1
CD33
NeoDegrader P1
Anti-CD33 AB1 Compound (Id) linker
[3]
Anti-CD33 AB1 Compound (Ie)
Anti-CD33 AB1
CD33
NeoDegrader P1
Anti-CD33 AB1 Compound (Ie) linker
[3]
Anti-CD33 AB1 Compound (If)
Anti-CD33 AB1
CD33
NeoDegrader P6
Anti-CD33 AB1 Compound (If) linker
[3]
Anti-CD33 AB1 Compound (Ig)
Anti-CD33 AB1
CD33
NeoDegrader P2
Anti-CD33 AB1 Compound (Ig) linker
[3]
Anti-CD33 AB1 Compound (Ih)
Anti-CD33 AB1
CD33
NeoDegrader P1
Anti-CD33 AB1 Compound (Ih) linker
[3]
Anti-CD33 AB1 Compound (Ii)
Anti-CD33 AB1
CD33
NeoDegrader P1
Anti-CD33 AB1 Compound (Ii) linker
[3]
Anti-CD33 AB1 Compound (Ik)
Anti-CD33 AB1
CD33
NeoDegrader P14
Anti-CD33 AB1 Compound (Ik) linker
[3]
Anti-CD33 AB1 Compound (Il)
Anti-CD33 AB1
CD33
NeoDegrader P14
Anti-CD33 AB1 Compound (Il) linker
[3]
Anti-CD33 AB1 Compound (Im)
Anti-CD33 AB1
CD33
NeoDegrader P14
Anti-CD33 AB1 Compound (Im) linker
[3]
Trastuzumab-Compound (lj)
Trastuzumab
ERBB2
NeoDegrader P1
Trastuzumab-Compound (lj) linker
[1]
Rituximab-Compound (lj)
Rituximab
MS4A1
NeoDegrader P1
Rituximab-Compound (lj) linker
[1]
Pertuzumab-Compound (lj)
Pertuzumab
ERBB2
NeoDegrader P1
Pertuzumab-Compound (lj) linker
[1]
Anti-CD33 AB1 Compound (Ij)
Anti-CD33 AB1
CD33
NeoDegrader P1
Anti-CD33 AB1 Compound (Ij) linker
[3]
References
Ref 1 Neodegrader conjugates; 2021-10-07.
Ref 2 Neodegrader conjugates; 2021-10-07.
Ref 3 Neodegrader-anti-cd33 antibody conjugates; 2022-12-08.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.